HeartBeam, Inc. (BEAT) vs Nephros, Inc. (NEPH)

A side-by-side comparison of HeartBeam, Inc. and Nephros, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

Compare
HeartBeam, Inc. logo
BEAT
HeartBeam, Inc.
$32M
$0.58HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
Nephros, Inc. logo
NEPH
Nephros, Inc.
$33M
$3.02HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT

Total return — BEAT vs NEPH

growth of $100 · dividends reinvested · last 5y
BEAT -86.1% (-32.6%/yr)NEPH -54.6% (-14.6%/yr)NEPH compounded faster over this window
050100Start $10020222023202420252026$14$45
BEAT NEPH

BEAT vs NEPH: by the numbers

  • •NEPH is the larger company ($33M vs $32M market cap).
  • •NEPH is profitable (8.38% net margin) while BEAT runs a net loss (0.00%).

Metrics side by side

Valuation

MetricBEATNEPH
P/E ratioN/A19.03
Forward P/EN/A19.28
P/S ratioN/A1.58
P/B ratio3.962.74
EV / EBITDAN/A16.41

Profitability

MetricBEATNEPH
Gross margin0.00%60.31%
Operating margin0.00%7.92%
Net margin0.00%8.38%
ROE-248.21%14.51%
ROIC-249.58%12.67%

Growth (annualized)

MetricBEATNEPH
Revenue CAGR (5Y)N/A16.99%
Total return CAGR (5Y)N/A-15.93%

Frequently asked

Is BEAT or NEPH more profitable?
NEPH runs the higher net margin — BEAT at 0.00% versus NEPH at 8.38%.

Go deeper

Full BEAT analysisFull NEPH analysisInteractive comparison tool

Dig into the metrics

Nephros P/E ratioHeartBeam ROENephros ROEHeartBeam operating marginNephros operating marginHeartBeam revenue growthNephros revenue growthHeartBeam free cash flowNephros free cash flow

HeartBeam & Nephros appear in these rankings

Fastest Revenue Growth Stocks

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.